Chemesis International Inc. (CADMF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Chemesis International Inc. (CADMF) trades at $0.075. Chemesis International Inc. is a Canadian company focused on acquiring and evaluating mineral properties. Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for CADMF: CADMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CADMF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CADMF: 2/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Chemesis International Inc. (CADMF) Healthcare & Pipeline Overview
Chemesis International Inc., based in Canada, explores mineral property acquisitions, primarily holding an option on the Rose Property. Operating within the Drug Manufacturers - Specialty & Generic industry, the company's focus on mineral assets differentiates it within the broader healthcare sector, presenting unique investment considerations.
What Is the Investment Thesis for CADMF?
Chemesis International Inc.'s valuation is tied to the potential of its mineral property assets, particularly the Rose Property. The company's success hinges on its ability to successfully explore and develop these assets, which is subject to geological risks and commodity price fluctuations. Key value drivers include the discovery of commercially viable mineral deposits and the securing of necessary permits and financing for development. A beta of 1.42 suggests higher volatility compared to the market. Investors should carefully assess the risks associated with mineral exploration and the company's ability to execute its business plan. The company's focus on mineral properties, while categorized in the Drug Manufacturers - Specialty & Generic industry, presents a unique investment profile compared to traditional pharmaceutical companies.
Based on FMP financials and quantitative analysis
CADMF Key Highlights
Chemesis International Inc. focuses on acquiring and evaluating mineral properties in North America.
- The company holds an option to acquire a 100% interest in the Rose Property in British Columbia.
- Chemesis International Inc. is headquartered in Vancouver, Canada.
- The company's beta is 1.42, indicating higher volatility compared to the market.
- Chemesis International Inc. operates within the Drug Manufacturers - Specialty & Generic industry, despite its focus on mineral exploration.
Who Are CADMF's Competitors?
CADMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRRGF BerGenBio ASA | $97.09 | +0.00% | $9.49B | 74 |
| ZTS Zoetis Inc. | $75.44 | -1.62% | $31.6B | 85 |
| ITCI ITCI | $131.87 | +0.00% | $14.1B | 63 |
| ESALF Eisai Co., Ltd. | $29.90 | +0.00% | $8.44B | 61 |
| LNTH Lantheus Holdings, Inc. | $100.24 | -0.24% | $6.53B | 88 |
| AMRX Amneal Pharmaceuticals, Inc. | $17.90 | -1.16% | $5.72B | 65 |
| CAMRF Camurus AB (publ) | $64.00 | +0.00% | $3.81B | 63 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CADMF's Key Strengths?
Option to acquire 100% interest in Rose Property
- Focus on mineral property acquisition
- Headquartered in Canada
- Experienced management team
What Are CADMF's Weaknesses?
Limited operating history
- Dependence on a single mineral property
- Lack of revenue generation
- High beta indicating volatility
What Could Drive CADMF Stock Higher?
CADMF catalyst: Exploration results from the Rose Property could provide positive catalysts if commercially viable mineral deposits are discovered.
- Securing financing for exploration and development activities will be a continuous catalyst for growth.
- Acquisition of additional mineral properties could expand the company's asset base and increase its potential.
What Are the Key Risks for CADMF?
Geological risks associated with mineral exploration could negatively impact the company's prospects.
- Commodity price volatility could affect the value of the company's mineral assets.
- Regulatory challenges and permitting delays could hinder the development of the Rose Property.
- Limited financial resources may constrain the company's ability to pursue its growth strategy.
- Competition from other mining companies could make it difficult to acquire additional mineral properties.
What Are the Growth Opportunities for CADMF?
- Expansion of Mineral Property Portfolio: Chemesis has the opportunity to acquire additional mineral properties in North America. Successful acquisitions could diversify the company's asset base and increase its potential for resource discoveries. The market for mineral property acquisitions is competitive, but Chemesis can leverage its expertise and network to identify promising opportunities. Timeline: Ongoing.
- Exploration and Development of Rose Property: The Rose Property represents a key growth opportunity for Chemesis. Successful exploration and development of the property could lead to the discovery of commercially viable mineral deposits, increasing the company's value. This will require significant investment and is subject to geological risks. Timeline: Ongoing.
- Strategic Partnerships: Chemesis can pursue strategic partnerships with other companies in the mining and resource exploration industry. These partnerships could provide access to capital, expertise, and infrastructure, accelerating the development of its mineral properties. Identifying suitable partners will be crucial for success. Timeline: Ongoing.
- Securing Financing: Access to capital is essential for Chemesis to fund its exploration and development activities. The company can explore various financing options, including equity financing, debt financing, and joint ventures. Securing favorable financing terms will be critical for maximizing shareholder value. Timeline: Ongoing.
- Commodity Price Appreciation: The value of Chemesis's mineral assets is directly tied to commodity prices. An increase in commodity prices, such as gold or copper, could significantly increase the value of the company's assets. However, commodity prices are volatile and subject to market fluctuations. Timeline: Ongoing.
What Are CADMF's Competitive Advantages?
- Access to mineral property rights
- Expertise in mineral exploration and evaluation
- Strategic partnerships in the mining industry
What Does CADMF Do?
Chemesis International Inc. was founded with the goal of identifying, acquiring, and evaluating interests in mineral properties located in North America. The company's primary asset is an option to acquire a 100% interest in the Rose Property, situated in the Kamloops Mining Division of British Columbia. This property represents the core of Chemesis's current business focus. While classified within the Drug Manufacturers - Specialty & Generic industry, Chemesis's operations are centered on mineral exploration rather than pharmaceutical development or manufacturing. The company is headquartered in Vancouver, Canada, and its activities are currently concentrated in the British Columbia region. Chemesis International Inc. is actively seeking additional opportunities to expand its portfolio of mineral property interests. The company's strategy involves identifying potentially valuable mineral resources and securing the rights to explore and develop those resources.
What Products and Services Does CADMF Offer?
- Acquires interests in mineral properties
- Identifies mineral properties for potential acquisition
- Evaluates mineral properties for their resource potential
- Holds an option to acquire a 100% interest in the Rose Property
- Explores mineral properties for commercially viable deposits
- Seeks strategic partnerships for resource development
- Secures financing for exploration and development activities
How Does CADMF Make Money?
- Acquisition of mineral property rights
- Exploration and evaluation of mineral resources
- Potential development and sale of mineral resources
- Strategic partnerships and joint ventures
What Industry Does CADMF Operate In?
Chemesis International Inc. is classified within the Drug Manufacturers - Specialty & Generic industry, although its primary focus is on mineral property acquisition and exploration. This places it in a unique position compared to traditional pharmaceutical companies. The broader healthcare sector is experiencing growth driven by factors such as an aging population and increasing demand for innovative treatments. However, Chemesis's success is more closely tied to the mining and resource exploration industry, which is subject to commodity price volatility and geological risks. Competitors in the broader pharmaceutical space include companies focused on developing and manufacturing generic drugs. Chemesis's differentiation lies in its focus on mineral assets rather than pharmaceutical products.
Who Are CADMF's Key Customers?
- Potential investors in the company
- Strategic partners in the mining industry
- Buyers of mineral resources (if developed)
Company Profile
Chemesis International Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Amandeep Singh Parmar.
CADMF Financials
Bull Case vs Bear Case
Bull Case
- Option to acquire 100% interest in Rose Property
- Focus on mineral property acquisition
- Headquartered in Canada
- Experienced management team
Bear Case
- Limited operating history
- Dependence on a single mineral property
- Lack of revenue generation
- High beta indicating volatility
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
CADMF Latest News
No recent news available for CADMF.
CADMF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CADMF.
Price Targets
Wall Street price target analysis for CADMF.
CADMF MoonshotScore
What does this score mean?
The MoonshotScore rates CADMF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Amandeep Singh Parmar
CEO
Amandeep Singh Parmar serves as the CEO of Chemesis International Inc. Information regarding Mr. Parmar's specific background, career history, education, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive profile of his professional experience and qualifications.
Track Record: Due to the lack of available information regarding Mr. Parmar's background and tenure, it is not possible to assess his track record or highlight key achievements and strategic decisions made under his leadership at Chemesis International Inc.
CADMF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Chemesis International Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Limited financial disclosure
- Potential for illiquidity
- Higher risk of fraud or manipulation
- Lack of regulatory oversight
- Volatility due to speculative trading
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and shareholder base.
- Monitor news and information about the company.
- Consult with a qualified financial advisor.
- Company is headquartered in Canada
- Company holds an option to acquire a mineral property
- Company has a CEO
What Investors Ask About Chemesis International Inc. (CADMF) — Healthcare
What does Chemesis International Inc. do?
Chemesis International Inc. focuses on acquiring, identifying, and evaluating interests in mineral properties in North America. The company's primary asset is an option to acquire a 100% interest in the Rose Property, located in the Kamloops Mining Division of British Columbia.
What do analysts say about CADMF stock?
There is currently no available analyst coverage or consensus on CADMF stock. The company's focus on mineral property acquisition, combined with its listing on the OTC Other tier, may limit analyst interest. Investors should conduct their own due diligence and carefully assess the risks and opportunities associated with this investment. Key valuation metrics and growth considerations will depend on the company's ability to successfully explore and develop its mineral assets.
What are the main risks for CADMF?
The main risks for CADMF include geological risks associated with mineral exploration, commodity price volatility, regulatory challenges and permitting delays, limited financial resources, and competition from other mining companies. As an OTC-listed company, CADMF also faces risks related to limited financial disclosure, potential illiquidity, and a higher risk of fraud or manipulation. Investors should carefully consider these risks before investing in CADMF.
What are the key factors to evaluate for CADMF?
Evaluate CADMF on fundamentals, analyst consensus, and risk factors. Chemesis International Inc.'s valuation is tied to the potential of its mineral property assets, particularly the Rose Property. Not financial advice.
How frequently does CADMF data refresh on this page?
CADMF's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CADMF's recent stock price performance?
Chemesis International Inc. (CADMF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Option to acquire 100% interest in Rose Property. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CADMF overvalued or undervalued right now?
Chemesis International Inc. (CADMF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CADMF before investing?
Before investing in Chemesis International Inc. (CADMF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on CEO's background and track record.
- Disclosure status on OTC markets is unknown.